SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
Issues related to climate change and emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA New | — |
| CHRIS SWONGER | — |
Energy/Nuclear ENG
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA New | — |
Medical/Disease Research/Clinical Labs MED
H.R.605/S.275, Medicare Home Infusion Site of Care Act of 2015; H.R.6, 21st Century Cures Act; issues related to patient infusion therapy.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA New | — |
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Defense DEF
FY2017 National Defense Authorization Act. FY2017 Department of Defense Appropriations; P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures. Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Taxation/Internal Revenue Code TAX
H.R.160, Protect Medical Innovation Act of 2015; S.149, Medical Device Access and Innovation Protection Act; P.L.114-113, Protecting Americans from Tax Hikes Act of 2015 and Consolidated Appropriations Act, 2016. Tax reform; international tax issues; the repeal of the medical device excise tax; manufacturing and taxes.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS SWONGER | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies. FY2017 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues. FY2017 Department of Defense Appropriations; chemical and biological counter measures. FY2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; medical device funding and policy. P.L.114-113, Consolidated Appropriations Act, 2016; chemical and biological counter measures and funding issues.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
| CHRIS SWONGER | — |
Aviation/Airlines/Airports AVI
Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Homeland Security HOM
Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS) and U.S. Customs and Border Protection (CBP). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions. FY2017 Department of Homeland Security Appropriations; Transportation Security Administration (TSA) funding issues.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Torts TOR
H.R.526, Furthering Asbestos Claim Transparency (FACT) Act of 2015; S.357, FACT Act; H.R.1927, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016; issues related to tort reform.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA New | — |
| CHRIS SWONGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.